Ayodele Osasona, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Atlanta, GANPI 1992143382
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (42.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 65.0% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $8,449 and has fallen 97.1% since, to $242 in 2025.
Across 116 payments — averaging $205.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$16K
- Atricure, Inc.$4K
- Edwards Lifesciences$1K
- Abbott$1K
- Corcym Inc$407
- Abiomed$195
- plus $853 from 11 others
What the payments were for
- Travel & lodging$6,47027%
- Food & beverage$4,22518%
- Education$10,18343%
- Other$3,00013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 28 | $15,512 |
| Atricure, Inc. | 24 | $4,105 |
| Edwards Lifesciences | 21 | $1,470 |
| Abbott | 14 | $1,336 |
| Corcym Inc | 6 | $407 |
| Abiomed | 3 | $195 |
| Johnson & Johnson(2 entities) | 3 | $164 |
| Conmed Corporation | 5 | $144 |
| E.r. Squibb & Sons, L.L.C. | 1 | $103 |
| Merck | 1 | $100 |
| Novartis | 1 | $90 |
| Getinge USA Sales, LLC | 3 | $68 |
| Baxter Healthcare | 1 | $67 |
| Angiodynamics, Inc. | 1 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| La Jolla Pharmaceutical Company | 1 | $23 |
| Werfen USA LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,878 in reported general payments places this provider in the 80th percentile of 144 thoracic surgery (cardiothoracic vascular surgery) providers in Georgia.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 26 | $197 |
| Potassium Chloride | 12 | $77 |
| Metoprolol Tartrate | 14 | $74 |
| Furosemide | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Atlanta
- Manu SanchetiAtlanta$805K
- John PuskasAtlanta$332K
- Douglas MurphyAtlanta$254K
- Ezequiel MolinaAtlanta$215K
- Gaetano PaoneAtlanta$134K
- Michael HalkosAtlanta$102K
- Allan PickensAtlanta$87K
- Bradley LeshnowerAtlanta$63K
- Kimberly HolstAtlanta$52K
- William KeelingAtlanta$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.